Publications by authors named "Gennaro Cretella"
Article Synopsis
- Parkinson's disease (PD) shows similar lifetime and recent headache prevalence rates compared to controls, with no significant differences in tension-type headaches or migraines.
- Patients with migraines and those treated with dopamine agonists (DAs) often experience headache remission after motor symptoms start, while overall mood depression is more severe in PD patients with migraines.
- The study suggests that although headache prevalence in PD aligns with general rates, changes in the dopaminergic system and treatments may influence the course of migraine symptoms.
Background: About 15% to one third of migraineurs experience aura symptoms. Aura is a reversible focal neurological phenomenon involving visual, sensory, speech, and motor symptoms that usually precede migraine pain. Monoclonal antibodies against calcitonin-related peptide (anti- CGRP mAbs) are effective in preventing chronic and episodic migraine, but little is known about their effectiveness on specifically preventing migraine with aura.
View Article and Find Full Text PDF